title: In vivo imatinib sensitivity in a patient with GI stromal tumor bearing a PDGFRA deletion DIM842-844.
authors.affiliation: Moores Cancer Center, University of California, San Diego, La Jolla, CA pfanta@ucsd.edu.
authors.forename: Paul T
authors.initials: PT
authors.lastname: Fanta
authors.affiliation: Moores Cancer Center, University of California, San Diego, La Jolla, CA.
authors.forename: Jason K
authors.initials: JK
authors.lastname: Sicklick
authors.affiliation: University of Michigan, Ann Arbor, MI.
authors.forename: Bryan L
authors.initials: BL
authors.lastname: Betz
authors.affiliation: Moores Cancer Center, University of California, San Diego, La Jolla, CA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Peterson
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use*; D001706:Biopsy; D004252:DNA Mutational Analysis; D005091:Exons; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000235:genetics*; D017353:Gene Deletion; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D008297:Male; D009154:Mutation; D009336:Necrosis; D009362:Neoplasm Metastasis; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D020796:Receptor, Platelet-Derived Growth Factor alpha